Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 889 — 3-yr total 889
Operates in Medical Devices — Distribution. Per the activity note to the FY2024 annual report, the company trades in medical equipment and medical supplies through re-export. Parent company is Estonian private company MN Medical.
Subsidiary of Shezghuduli Pasukhismgeblobis Kerdzo Company MN MEDICAL (100.0%)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,535 | 6,301 | 4,916 | 1,489 | 2,124 | 1,852 | 2,284 | -16.1% |
| Total COGS | 6,144 | 5,909 | 4,603 | 989 | 1,415 | 1,560 | 2,069 | -16.6% |
| Gross Profit | 391 | 393 | 313 | 500 | 709 | 292 | 215 | -9.5% |
| Gross Margin | 6.0% | 6.2% | 6.4% | 33.6% | 33.4% | 15.7% | 9.4% | |
| 95 | 254 | 254 | 248 | 457 | 562 | 172 | +10.4% | |
| EBITDA | 295 | 139 | 59 | 252 | 252 | 271 | 43 | -27.5% |
| EBITDA Margin | 4.5% | 2.2% | 1.2% | 16.9% | 11.8% | 14.6% | 1.9% | |
| Total D&A | 2 | 2 | 1 | 1 | 1 | 0 | 0 | -33.7% |
| EBIT / Operating Income | 293 | 136 | 58 | 251 | 251 | 271 | 43 | -27.5% |
| Total Interest Expense | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -39.1% |
| 0 | 33 | 21 | 238 | 87 | 202 | 6 | nmf | |
| Profit Before Tax | 293 | 169 | 79 | 489 | 163 | 473 | 37 | -29.2% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 195 | 169 | 78 | 489 | 163 | 473 | 37 | -24.3% |
| Net Margin | 3.0% | 2.7% | 1.6% | 32.8% | 7.7% | 25.6% | 1.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.